Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the United States Food and Drug Administration (FDA) for Ryaltris™ Nasal Spray for the Treatment of Symptoms of Seasonal Allergic Rhinitis in Adults and Pediatric Patients 12 Years of Age and Older

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) for Ryaltris™, … Read More

Rise Of Obesity Amongst The Children During The Pandemic And The Way Forward

The author of the article is Dr Ruchi Parikh – Consultant (Paediatric Endocrinology) Obesity amongst children and adolescents has been a cause of concern since last few decades. What is … Read More

A pilot study reveals low blood sugar at birth and genetic diseases, are important underlying cause for a common form of epilepsy in young Indian children

In a first-of-its-kind Medgenome Labs, a genomics and clinical data driven diagnostics and drug discovery research company conducted a study in partnership with doctors from Santokba Durlabhji Memorial Hospital, Jaipur, … Read More

Jupiter Hospital conducts India’s first pediatric living donor small intestinal transplant

When nine-year old Om from Maharashtra complained of severe abdominal pain in August 2020, little did his parents know that he would end up losing his entire small intestine. Investigations … Read More